Skip to main content
Swing Capital

Vikas Lifecare Ltd

NSE: VIKASLIFE BSE: 542655FMCG

Incorporated in 1995, Vikas Lifecare Ltd is under four business segments which is trading(Base polymers, additives and chemicals meant for plastic processing, commodity compounds( Manufacturing up-cycled polymer compounds like EVA, PVC, PP,PE etc.), Environment protection( Recycling and up-cycling of plastic waste to fulfill EPR) and FMCG & Healthcare which can be further divided into different major segments which include Smart product Business( Smart gas and water meters), Polymer & Chemical Business (Recycling materials, trading and manufacturing of Polymer Compounds), FMCG segment (Agro Product), Infra Products( Steel fittings & Steel Bars), Food grade piping system for Jal Jeevan Mission. [1]

₹1.46
52W: ₹1.05 — ₹3.16
PE 2.45 · Book ₹3.6 · -59% vs book
Market Cap₹271 Cr
Stock P/E2.45Price to Earnings
ROCE1.8%Return on Capital
ROE1.69%Return on Equity
Div. Yield0%Face Value ₹1

Strengths

  • +Stock is trading at 0.42 times its book value

Weaknesses

  • −Promoter holding is low: 14.2%
  • −Company has a low return on equity of -1.10% over last 3 years.
  • −Earnings include an other income of Rs.154 Cr.

Shareholding Pattern

Promoters14.2%
FIIs0.26%
DIIs0%
Public85.53%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters14.21%14.2%▼0.014.2%14.2%14.2%14.2%14.2%14.2%
FIIs0.28%0.5%▲0.20.49%▼0.00.46%▼0.00.38%▼0.10.3%▼0.10.28%▼0.00.26%▼0.0
DIIs0%0%0%0%0%0%0%0%
Public85.51%85.29%▼0.285.31%▲0.085.34%▲0.085.43%▲0.185.5%▲0.185.53%▲0.085.53%

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales10495123921301121308914197
Expenses102991229112911414891143112
Operating Profit2-4101-2-19-2-2-15
OPM %2%-4%1%0%1%-2%-14%-3%-2%-16%
Net Profit7-32-25-51128-3-15
EPS ₹0.05-0.020.01-0.010.03-0.0300.69-0.02-0.08

AI Insights

Revenue Trend

TTM revenue at ₹456Cr, down 1.7% YoY. OPM at -8%.

Debt Position

Borrowings at ₹71Cr. Debt-to-equity ratio: 0.15x. Healthy balance sheet.

Capex Cycle

CWIP at ₹1Cr (2% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 0% (+0.00pp change). FIIs: 0.26% (+0.24pp change). Promoters hold 14.2%.

Margin & Efficiency

ROCE declining from 0% (Mar 2015) to -2% (Mar 2025). Working capital days: 111.

Valuation

PE 2.45x with 1.8% ROCE. Price is -59% above book value of ₹3.6. Dividend yield: 0%.

Recent Announcements